We use the state-of-the-art 6500 Sciex LC-MS/MS system to identify and quantify the dozens of pesticides mandated by BCC at ppb levels. We are light years ahead of our competitors!
Why waste your time when our in-house operation provides an accurate and timely turnaround time for heavy metals analysis. We utilize an EPA validated ICP-MS methodology, while most of the labs in the industry outsource the analysis.
A mycotoxin and/or bacterial contamination can ruin a crop. Protect your investment with our discounted pre-harvest testing services before it becomes a problem.
Our Head-Space GC/MS method provides the speed and reliability you need to ensure the precise reporting of trace levels solvents in your concentrates. The lack of sample preparation step eliminates the possibility of a chemical contamination.
Simply put, our statistically significant analysis will give you the data you need to keep your edibles compliant. We have a proven methodology for most matrices.
Differentiate your product from competitors’ with the most accurate LC-MS/MS based quantitative terpene method in California.
It doesn’t take a rocket scientist to quantify all CA mandated cannabinoids. Fortunately, our scientists can do this in their sleep.
FILTH & FOREIGN MATERIAL
Simple low-resolution microscopic images are taken to determine if biological specimens are detectable suggesting the presence of pests or other macro-contaminants.
Too much moisture will have adverse affects on your yield. We can document the water activity of your product at any time point in your operation to ensure the percentage remains below the regulatory threshold.
Kaleb holds multiple degrees in chemistry and did his Ph.D. research at the University of California Berkeley. He has experience working with analytical chemistry method development, drug delivery device analysis, and API formulations at pharmaceutical titans such as Genentech, Novartis, and Dow. But his aptitude for high-throughput lab production came while working at SCBT.
Eric has over 20 years of cumulative experience at pharmaceutical companies such as Gilead and Reset. He received his Ph.D. in Immunology from Stanford University and is an author on over a dozen scientific publications. He was a significant contributor in the FDA drug approval of Telavancin, Sofosbuvir, Velpatasvir, and Voxilaprevir.
Siheen has over 15 years at The Bernstein Companies, one of the oldest investment firms in Washington D.C. overseeing $1.5 billion in tax credit transactions and tax credit asset management and compliance. She has also managed dozens of Real Estate accountants at the firm as the accounting department manager.